This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

THOMAS H. MILLER, M.D.; JAMES R. DELANEY, M.D.

Arch Derm Syphilol. 1949;60(2):196-205.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DURING the past twenty-five years bismuth has been employed extensively in the treatment of disease. It has proved an effective agent not only in syphilotherapy but also as an empiric remedy in a number of varied dermatoses, in the majority of which the etiologic basis has not been clearly established. Until recently, salts of bismuth have been administered by intramuscular injection and the results of oral administration of the drug have been disappointing, not because of a poor therapeutic response but because of gastrointestinal intolerance. Sodium bismuth triglycollamate (bistrimate®),¹ one of the newer bismuth salts available for oral administration, gives promise of being therapeutically effective without producing a high percentage of severe reactions. Gross and Wright² have reported satisfactory results from the use of this agent in the treatment of syphilis and a number of dermatoses known to be responsive to bismuth therapy. Sawicky³ has . . . [Full Text PDF of this Article]

Author Affiliations
DETROIT

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?